Kalender
Nyheder
Markeder
Råvarer
Indekser
Aktier
Valuta
Krypto
Obligationer
Indikatorer
Lande
Prognoser
Råvarer
Indekser
Valuta
Krypto
Obligationer
Lande
Indikatorer
Kalender
Nyheder
Markeder
Råvarer
Indekser
Aktier
Valuta
Krypto
Obligationer
Indtjening
Ferie
Lande
Usa
Forenede Kongerige
Euroområdet
Australien
Canada
Japan
Kina
Brasilien
Rusland
Indien
Mere Lande
Indikatorer
Rentesats
Inflation-Rate
Arbejdsløshed Rate
Bnp-Vækst
Bnp Per Capita
Betalingsbalance
Guldreserver
Statsgældsforvaltningen
Crude Oil Produktion
Benzin Priser
Kreditvurdering
Mere Indikatorer
Prognoser
Råvarer
Indekser
Valuta
Krypto
Obligationer
Lande
Indikatorer
Apps
App Store
Google Play
Twitter
Tectonic Therapeutic | Salgsomkostninger Og Administration
Selling And Administration Expenses
Lave om
Dato
Adcock Ingram Holdings
ZAR 1.05B
50.17M
2024-12
Alnylam Pharmaceuticals
USD 239.95M
55.39M
2025-03
Celltrion
KRW 239.71B
17.94B
2024-09
Cspc Pharmaceutical
CNY 2.1B
22.82M
2024-09
Dianthus Therapeutics
USD 6.83M
287K
2024-12
Ecofibre
AUD 8.03M
1.38M
2024-06
Gilead Sciences
USD 1.26B
603M
2025-03
Ionis Pharmaceuticals
USD 76M
12.08M
2025-03
Kangmei Pharma
CNY 245.26M
66.07M
2024-09
Knight Therapeutics
CAD 25.48M
119K
2024-09
Laboratorios Farma
EUR 32.57M
26.69M
2024-06
MacroGenics
USD 27.81M
13.71M
2024-12
Malin Corporation
EUR 700K
1.6M
2024-06
Medical Developments International
AUD 7.07M
15.4M
2024-06
Neuren Pharmaceuticals
AUD 2.33M
47K
2024-12
Organigram Holdings
CAD 17.19M
2.88M
2024-12
Pfizer
USD 3.01B
1.27B
2025-03
Pharma Mar
EUR 13.68M
450K
2025-03
Qiagen NV
USD 141.71M
1.05M
2024-12
Roche Holding
CHF 3.61B
381M
2024-12
Sanofi
EUR 2.22B
980M
2025-03
Sarepta Therapeutics
USD 163.87M
35.67M
2024-12
Sartorius
EUR 231.9M
13.6M
2025-03
Sino Biopharmaceutical
CNY 5.31B
1.89B
2024-12
Takeda
JPY 270.59B
2.31B
2024-12
Tilray
USD 72.38M
4.99M
2024-11
Zz Pientze Pharmaceu
171.29M
130.03M
2025-03
Tectonic Therapeutic Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.